Clinical Trials

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06323265 2024-03-27

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

50 enrolled

Extensive Stage Small Cell Lung Cancer

NCT06195189 2024-03-25

WU-KONG36

Carcinoma, Non-Small-Cell Lung

NCT06277674 2024-03-08

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06267144 2024-02-20

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05647590 2024-01-30

SBRT/RT in Oligometastatic Stage IV NSCLC

10 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06207292 2024-01-16

STARTNEWERA-OM

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05128630 2023-09-28

DEDALUS

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05978401 2023-08-07

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

152 enrolled

Advanced Non-Small Cell Lung Cancer

NCT05873790 2023-05-24

Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05157776 2023-05-09

A Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver Mutations

72 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05842018 2023-05-03

Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Non Small Cell Lung Cancer Recurrent

NCT03975114 2023-03-24

MILES-5

460 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02428049 2023-01-20

Radiation Pneumonitis After SBRT for NSCLC

105 enrolled

Lung Neoplasms

NCT05532527 2022-09-08

NSCLC

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05507606 2022-08-19

Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

500 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05472467 2022-07-25

IMCORT-2

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05273814 2022-07-13

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04690686 2022-03-08

Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

46 enrolled

Squamous Non-small Cell Lung Cancer

NCT05209256 2022-01-26

Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC

Phase 2/3 Unknown

90 enrolled

NSCLC

NCT05170581 2021-12-28

Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05098990 2021-10-29

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Phase 4 Unknown

328 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

63 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04990063 2021-08-04

Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1 Unknown

20 enrolled

Advanced Non-small Cell Lung Cancer

NCT02448797 2021-07-20

EVIDENCE

320 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04951648 2021-07-07

A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation

220 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04950400 2021-07-06

A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

NCT03986528 2021-02-23

Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Unknown

334 enrolled

NSCLC

NCT04672759 2020-12-17

A Real-world Study of Durvalumab for Lung Cancer in China

100 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT03267654 2020-08-03

Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abundance

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03758677 2020-07-23

Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation

Carcinoma, Non-Small-Cell Lung

NCT04333004 2020-04-03

Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy

Gut Microbiota

NCT03656094 2019-12-09

Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors

98 enrolled

Non-small Cell Lung Cancer Metastatic

NCT04124731 2019-10-11

Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)

98 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT03987087 2019-06-14

A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC

68 enrolled

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03971214 2019-06-04

PICARES

Phase 1 Unknown

6 enrolled

Small Cell Lung Carcinoma

NCT03664115 2018-09-10

Itraconazole in Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03523234 2018-09-05

Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage

300 enrolled

Small Cell Lung Carcinoma

NCT03589950 2018-07-18

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Lung Neoplasms

NCT02844114 2017-03-31

LCKY2015-21(x)

Carcinoma, Non-Small-Cell Lung

NCT03002844 2016-12-28

EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02873416 2016-10-07

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

Precision Cell Immunotherapy

NCT02906150 2016-09-19

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02862587 2016-09-02

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Precision Cells

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

330 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02841228 2016-07-22

Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer